Hidenori Matsusaka

Title: Hidenori Matsusaka: Innovator in Gene Therapy

Introduction

Hidenori Matsusaka is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of gene therapy, particularly through his innovative work with Paramyxovirus vectors. His research focuses on the effective transfer of angiogenic genes into individual tissues, which has important implications for medical treatments.

Latest Patents

Matsusaka holds a patent for a "Paramyxovirus vector encoding angiogenesis gene and use thereof." This invention provides Paramyxovirus vectors that encode angiogenic genes, enabling effective gene transfer into ischemic tissues. The FGF2 gene, when transferred into ischemic tissues in vivo, induces the expression of angiogenic genes without causing edema and prevents necrosis due to ischemia. This technology is particularly suitable for gene therapy targeted at ischemic tissues.

Career Highlights

Hidenori Matsusaka is associated with Dna Vec Research Inc., where he continues to advance his research in gene therapy. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from ischemic conditions.

Collaborations

Matsusaka collaborates with notable colleagues, including Yoshikazu Yonemitsu and Katsuo Sueishi. Their combined expertise contributes to the innovative research being conducted at Dna Vec Research Inc.

Conclusion

Hidenori Matsusaka's contributions to gene therapy through his patented innovations highlight the potential for advanced medical treatments. His work continues to pave the way for future developments in the field.